News

Homrich Berg Expands Wealth Management with WMS Partners Deal

Homrich Berg Expands Wealth Management with WMS Partners Deal

Homrich Berg Welcomes WMS Partners in Strategic Acquisition

Homrich Berg, a prominent wealth management firm based in Atlanta, is taking significant steps toward its expansion initiatives by announcing a definitive agreement to acquire WMS Partners, a $6.4 billion multi-family office. This strategic acquisition marks an important milestone for Homrich Berg as it strives to enhance its offerings and reach.

Understanding WMS Partners' Role in Wealth Management

WMS Partners has been providing comprehensive wealth management solutions since its inception in 1993. They have developed an impressive track record serving high and ultra-high-net-worth families with services such as trust and estate planning alongside private investments. Founded by industry veterans Tim Chase, David Citron, and Martin Eby, WMS has cultivated a team of over 80 dedicated professionals, which further solidifies its reputation within the financial sector.

A Statement from Leadership

Thomas Carroll, President and CEO of Homrich Berg, expressed his enthusiasm regarding the partnership, stating, "We are thrilled to join forces with WMS Partners, who we have long admired for their unwavering commitment to serving as fiduciary to client families. Our collaboration will only enhance our services, helping us better support clients facing complex planning and investment challenges in our pursuit to become the premier independent fee-only RIA in the Southeast."

Seamless Integration and Shared Value

Co-founder Martin Eby of WMS conveyed the importance of aligning with a firm that upholds strong values. He stated, "Our pledge to client families has always been to offer a permanent solution that serves multiple generations. Joining Homrich Berg allows us to fulfill that mission while continuing to prioritize our clients."

Impacts on Homrich Berg’s Growth Trajectory

This transaction is a pivotal moment in Homrich Berg's growth strategy as it extends its reach into the mid-Atlantic region. The acquisition comes in the wake of other significant developments for HB, including a strategic investment from TPG Growth and the launch of a new office in Tampa, Florida, which added a skilled 12-person team.

Scaling Together

Following the completion of this acquisition, Homrich Berg will manage over $24 billion in assets, solidifying its place as a leading player in the wealth management industry. With this merger, HB will expand its presence across ten offices in five states, supported by a workforce of over 300 professionals. All 21 WMS shareholders will transition into ownership roles at Homrich Berg, increasing the total number of shareholders to over 70.

Future Prospects for Homrich Berg

The move to acquire WMS Partners not only highlights Homrich Berg’s commitment to growth but also strengthens its capacity to serve clients more effectively. As a firm known for its fiduciary services, this new chapter will help Homrich Berg deliver on its promise of exceptional wealth management tailored to client needs. The dedicated leadership teams from both firms are focused on ensuring a seamless transition while maintaining the integrity that their clients expect.

Comprehensive Legal Support

In navigating this major transaction, WMS Partners enlisted Willkie Farr & Gallagher LLP as its legal counsel, while Alston & Bird LLP provided the legal support for Homrich Berg, ensuring all regulatory and compliance matters were aptly addressed.

About Homrich Berg

Founded in 1989, Homrich Berg stands as a national leader in independent wealth management. The firm prides itself on offering fiduciary, fee-only investment management and financial planning services to high-net-worth individuals, families, and not-for-profits across the United States, managing over $18 billion in assets. Their approach to wealth advisory is collaborative and deeply rooted in the goal of enhancing clients’ financial well-being.

About WMS Partners

WMS Partners has garnered recognition for its fee-only, fiduciary wealth management services since its establishment in 1993. Emphasizing open communication and collaboration, WMS has been dedicated to crafting tailored investment solutions for wealthy families. By joining forces with Homrich Berg, WMS Partners looks forward to benefiting from enhanced resources while continuing to uphold its legacy of client-first service.

Frequently Asked Questions

What is the significance of Homrich Berg acquiring WMS Partners?

This acquisition enhances Homrich Berg's service offerings and expands its asset management to over $24 billion, allowing it to better serve diverse client needs.

How long has WMS Partners been operating in wealth management?

WMS Partners was founded in 1993 and has since built a strong reputation for providing comprehensive wealth management solutions.

Who are the key figures in this acquisition?

Key figures include Thomas Carroll, President and CEO of Homrich Berg, and Martin Eby, co-founder of WMS Partners, who are both enthusiastic about the partnership.

What are the future plans for the combined firms?

The integrated firms aim to maintain a strong client-first approach while leveraging shared values to enhance client services and investment strategies.

What legal support was utilized for this transaction?

Willkie Farr & Gallagher LLP represented WMS Partners, while Alston & Bird LLP were the legal advisors for Homrich Berg, ensuring compliance throughout the process.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Smart Living Solutions Unveiled by Hisense at CES 2026

Updated Category News Views 136

Hisense Unveils Smart Living Innovations at CES 2026 Hisense has made headlines once again at CES 2026 by presenting an impressive array of smart living solutions that integrate seamlessly into everyday life. The company, recognized worldwide for its prowess in consumer electronics and home appliances, demonstrated its commitment to enhancing modern living through...

Continue Reading
Exploring the Innovations of Oncotelic Therapeutics Inc.

Updated Category News Views 103

Oncotelic Therapeutics: A Leader in Cancer Innovations Oncotelic Therapeutics Inc. (NASDAQ: OTLC), a pioneering clinical-stage biopharmaceutical company, is committed to advancing groundbreaking therapies in oncology and immunotherapy. The organization specializes in developing innovative treatments for difficult-to-treat cancers and rare diseases. This vision is...

Continue Reading
Introducing EMBREY Insights: A New Perspective on Investments

Updated Category News Views 128

Introducing EMBREY Insights: A New Publication for Investors New Publication Focuses on the Emerging Strength of Multifamily Investments EMBREY, a vertically integrated real estate investment company, recently announced the launch of its latest research periodical, EMBREY Insights. This new publication aims to deliver expert research and insights on multifamily investment...

Continue Reading
Oportun's Strategic Alliance with Findell Capital Management

Updated Category News Views 105

Oportun Enters Strategic Cooperation Agreement Oportun Financial Corporation (Nasdaq: OPRT), a dedicated financial services firm, has embarked on a groundbreaking journey by entering a multi-year cooperation agreement with Findell Capital Management LLC. This collaborative move marks a significant milestone in maintaining harmonious relations within the company’s...

Continue Reading
Nutricosmetics Market Expected to Surpass $15 Billion by 2033

Updated Category News Views 174

Nutricosmetics Market Overview The global nutricosmetics market is on a trajectory for substantial growth, with projections estimating a rise from USD 8.28 billion in the near future to USD 15.36 billion by 2033. According to industry insights, this growth represents a compound annual growth rate (CAGR) of 8.07% from 2026 to 2033. The increasing awareness regarding the...

Continue Reading